Skip to main content

Table 2 Correlations between PWV, body composition, metabolic parameters and medications

From: The relationship between various measures of obesity and arterial stiffness in morbidly obese patients

Independent variables Male (r) Female (r)
Age 0.61† 0.52†
Hypertension‡ 0.19 0.59†
Type 2 diabetes (yes/no) 0.46† 0.18
Visceral fat area (cm2) -0.18 0.25*
Fat mass (kg) -0.26 0.06
Fat free mass (kg) -0.15 -0.04
apo-B/apoA-1 ratio -0.29 0.10
Fasting insulin (mmol/L) 0.03 0.09
HOMA IR§ 0.10 0.13
Fasting glucose (mmol/L) 0.35* 0.24*
HbA1c (%) 0.27 0.31*
β-blocker (yes/no) 0.12 0.39†
Calsium-channel blocker (yes/no) 0.36* 0.24*
Inhibitors of the RAA-system (yes/no) 0.29* 0.14
Statins (yes/no) 0.39* 0.22
  1. *p < 0.05. †p < 0.001. ‡ Hypertension is defined by the patient receiving antihypertensive medication or having systolic bloodpressure ≥ 140 mmHg or diastoic blood pressure ≥ 90 mmHg. §Homeostasis Model Assessment Insulin Resistance